TOM STOPPARD did not write all the best lines in Shakespeare in Love, but the film's assertion that for a successful comedy all you need is "love and a bit with a dog" is unlikely to have been a Bard ...

Bioglan, the skincare firm, has ceased trading and called in administrators after talks with a potential US buyer collapsed, leaving the Hertfordshire firm at the mercy of its bankers. The company has ...

Bioglan Pharma, the biotech firm fighting for survival in the face of mounting debts, has again failed to get its results approved by its auditors. The company restated its most recent interim results ...

Bioglan has come good on its promise of support from its bankers, gaining a one-month reprieve from paying off its spiralling debt. But the terms of the repayments have yet to be re-negotiated, ...

Drugs company Bioglan is likely to announce a wide-ranging financial restructuring today, as it admits defeat in its attempt to buy a portfolio of skincare products from Bristol-Myers Squibb for $720m ...

BIOGLAN Pharma, the ailing dermatology business, put itself up for sale yesterday after being pressured into raising estimates of losses after an incomplete review by its auditors. Pre-tax losses for ...

BIOGLAN, the debt-troubled UK pharmaceutical company, has bought itself some time as it continues to negotiate with its bankers. The company has reached agreement with Quintiles Transnational to allow ...

UK skincare specialist Bioglan Pharma has called in administrators after last-ditch debt restructuring talks with its banks fell through. "(The talks) have failed to reach a satisfactory conclusion ...

TROUBLED Bioglan Pharma has put itself up for sale after revealing that a review of its controversial interim profits announcement had resulted in the loss increasing by £10.9m. Bioglan, which depends ...

DEBT-HEAVY biotech firm Bioglan, which has a secondary listing in Dublin, is close to a deal with banks to roll over its debts, sources close to the company said yesterday, as its shares surged as ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...